To put enafox in context, it helps to compare it to better-known substances with similar proposed benefits. The table below highlights key differences.
| Compound | Status | Human Trials | Regulatory Approval | Known Safety Profile |
|---|---|---|---|---|
| Enafox | Preclinical / Experimental | None | None | Very limited |
| Nicotinamide Riboside | Dietary Supplement | Multiple | GRAS (Generally Recognized as Safe) | Good, with mild side effects |
| Resveratrol | Dietary Supplement | Many | GRAS | Good, well-tolerated |
| Metformin | FDA-approved drug | Extensive | Yes (for diabetes) | Excellent, with known risks |
| Rapamycin | FDA-approved drug | Extensive | Yes (immunosuppressant) | Significant side effects |
As the table shows, enafox is in a completely different league from established compounds. It lacks the basic evidence that even a common supplement like nicotinamide riboside possesses.
